Evonik ups HPAPI capability in Germany and US as oncology market grows
Evonik has upped its capabilities in highly potent active pharmaceutical ingredients (HPAPI) citing the increased market growth of oncology drugs.
Evonik has upped its capabilities in highly potent active pharmaceutical ingredients (HPAPI) citing the increased market growth of oncology drugs.
Bend Research is expanding its commercial spray-dried dispersion (SDD) manufacturing with capital from new owners Capsugel in order to offer unique integrated capabilities, the firm says.